Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails.

Niu Y, Chang TM, Yeh S, Ma WL, Wang YZ, Chang C.

Oncogene. 2010 Jun 24;29(25):3593-604. doi: 10.1038/onc.2010.121. Epub 2010 May 3. Review.

PMID:
20440270
2.

Androgen receptor signaling in androgen-refractory prostate cancer.

Grossmann ME, Huang H, Tindall DJ.

J Natl Cancer Inst. 2001 Nov 21;93(22):1687-97. Review.

3.

Regulation of androgen receptor levels: implications for prostate cancer progression and therapy.

Burnstein KL.

J Cell Biochem. 2005 Jul 1;95(4):657-69. Review.

PMID:
15861399
4.

Manipulation of androgens and alterations in the androgen receptor axis in prostate cancer.

Nguyen MM, Wang Z.

Minerva Urol Nefrol. 2008 Mar;60(1):15-29. Review.

PMID:
18427432
5.

Androgen receptor involvement in the progression of prostate cancer.

Suzuki H, Ueda T, Ichikawa T, Ito H.

Endocr Relat Cancer. 2003 Jun;10(2):209-16. Review.

6.

Androgen action in the prostate gland.

Yadav N, Heemers HV.

Minerva Urol Nefrol. 2012 Mar;64(1):35-49. Review.

PMID:
22402316
7.

Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies.

Mimeault M, Batra SK.

Carcinogenesis. 2006 Jan;27(1):1-22. Epub 2005 Sep 29. Review.

8.
9.

Androgen receptor: role and novel therapeutic prospects in prostate cancer.

Taplin ME.

Expert Rev Anticancer Ther. 2008 Sep;8(9):1495-508. doi: 10.1586/14737140.8.9.1495. Review.

PMID:
18759700
10.

Androgen axis in prostate cancer.

Culig Z, Bartsch G.

J Cell Biochem. 2006 Oct 1;99(2):373-81. Review.

PMID:
16598769
11.

Androgen signaling and its interactions with other signaling pathways in prostate cancer.

Kaarbø M, Klokk TI, Saatcioglu F.

Bioessays. 2007 Dec;29(12):1227-38. Review.

PMID:
18008377
12.

Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer.

Scher HI, Buchanan G, Gerald W, Butler LM, Tilley WD.

Endocr Relat Cancer. 2004 Sep;11(3):459-76. Review.

13.

Drug insight: role of the androgen receptor in the development and progression of prostate cancer.

Taplin ME.

Nat Clin Pract Oncol. 2007 Apr;4(4):236-44. Review.

PMID:
17392714
14.

Androgen receptor action in hormone-dependent and recurrent prostate cancer.

Agoulnik IU, Weigel NL.

J Cell Biochem. 2006 Oct 1;99(2):362-72. Review.

PMID:
16619264
15.

Stem cells in prostate cancer: resolving the castrate-resistant conundrum and implications for hormonal therapy.

Sharifi N, Kawasaki BT, Hurt EM, Farrar WL.

Cancer Biol Ther. 2006 Aug;5(8):901-6. Epub 2006 Aug 28. Review.

PMID:
16855379
16.

Androgen receptor (AR) positive vs negative roles in prostate cancer cell deaths including apoptosis, anoikis, entosis, necrosis and autophagic cell death.

Wen S, Niu Y, Lee SO, Chang C.

Cancer Treat Rev. 2014 Feb;40(1):31-40. doi: 10.1016/j.ctrv.2013.07.008. Epub 2013 Aug 7. Review.

17.

The role of androgens and the androgen receptor in prostate cancer.

Debes JD, Tindall DJ.

Cancer Lett. 2002 Dec 10;187(1-2):1-7. Review.

PMID:
12359344
18.

Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence.

Taplin ME, Balk SP.

J Cell Biochem. 2004 Feb 15;91(3):483-90. Review.

PMID:
14755679
19.

Interaction of IGF signaling and the androgen receptor in prostate cancer progression.

Wu JD, Haugk K, Woodke L, Nelson P, Coleman I, Plymate SR.

J Cell Biochem. 2006 Oct 1;99(2):392-401. Review.

PMID:
16639715
20.

Hormonal therapy for prostate cancer: toward further unraveling of androgen receptor function.

Sharifi N.

Anticancer Agents Med Chem. 2009 Dec;9(10):1046-51. Review.

PMID:
19719456
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk